Stocks and Investing
Stocks and Investing
Thu, April 23, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steven Seedhouse Downgraded (BIIB) to Strong Sell on, Apr 23rd, 2020
Steven Seedhouse of Citigroup, Downgraded "Biogen Inc." (BIIB) to Strong Sell on, Apr 23rd, 2020.
Steven has made no other calls on BIIB in the last 4 months.
There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 3 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $311 on, Thursday, February 6th, 2020
- Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Increased Target to $361 on, Thursday, February 6th, 2020
These are the ratings of the 4 analyists that currently disagree with Steven
- Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $392 on, Friday, February 7th, 2020
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $410 on, Thursday, February 6th, 2020
- Brian Skorney of "Baird" Maintained at Sell with Increased Target to $290 on, Thursday, February 6th, 2020
- Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Held Target at $360 on, Monday, January 27th, 2020